MARKET

CODX

CODX

Co-Diagnostics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

16.93
0.00
0.00%
After Hours: 16.69 -0.24 -1.42% 19:55 06/04 EDT
OPEN
16.50
PREV CLOSE
16.93
HIGH
16.96
LOW
15.85
VOLUME
2.51M
TURNOVER
--
52 WEEK HIGH
29.72
52 WEEK LOW
0.6940
MARKET CAP
464.54M
P/E (TTM)
-51.1326
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CODX stock price target is 33.67 with a high estimate of 36.00 and a low estimate of 30.00.

EPS

CODX News

More
Co-Diagnostics: Why Traders Shouldn't Take COVID-19 Stocks Too Seriously
Seeking Alpha - Article · 3d ago
5 Stocks to Bank on May's Strong Market Rally
Zacks · 3d ago
Alnylam's NDA Accepted, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha - Article · 05/29 04:50
Co-Diagnostics (NASDAQ:CODX) Analysts Set Price Target Between $30 and $36
GlobeNewswire · 05/28 14:00
Top Ranked Momentum Stocks to Buy for May 27th
Zacks · 05/27 15:31
'Obvious' Shorts: The Highest Borrowing Fee Stocks In The U.S. Market Of May 2020
Seeking Alpha - Article · 05/27 15:00
Co-Diagnostics (CODX): Strong Industry, Solid Earnings Estimate Revisions
Zacks · 05/26 13:37
7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine
InvestorPlace · 05/22 14:05

Industry

Advanced Medical Equipment & Technology
-0.72%
Healthcare Equipment & Supplies
-1.30%

Hot Stocks

Symbol
Price
%Change

About CODX

Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. It also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The Company uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.
More

Webull offers kinds of Co-Diagnostics Inc stock information, including NASDAQ:CODX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CODX stock news, and many more online research tools to help you make informed decisions.